| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, Nebraska 68105
Adenosine 3',5'-cyclic monophosphate was injected i.p. into strain A mice receiving the chemical carcinogen 7,12-dimethylbenzanthracene topically on the interscapular area of the skin. Adenosine 3',5'-cyclic monophosphate increased the incidence of skin papillomas and squamous cell carcinomas in the 7,12-dimethylbenzanthracene-treated mice whereas 5'-adenosine monophosphate, the immediate metabolite of adenosine 3',5'-cyclic monophosphate, had no effect on the incidence of tumors in 7,12-dimethylbenzanthracene-treated mice.
1 This work was supported by American Cancer Society Grant BC-48A and National Cancer Institute Contract PH43-68-959.
2 Recipient of USPHS Postdoctoral Fellowship CA05220.
Received 2/19/74. Accepted 5/10/74.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |